Replimune Group, Inc.

REPL · XNAS

CIK 1737953fmd_1Q7JQ0GWZ3DZAEB25N5MNTAV1FManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard

Coverage: Apr 01, 2016 to Sep 30, 2026, 39 periods

AI-written

A model wrote this from the company's own SEC filings and our standardized facts. It is not reported fact, not an analyst's estimate, not a rating and not investment advice. Every claim shows what it rests on.